RBOT — Vicarious Surgical Income Statement
0.000.00%
Last trade - 00:00
- $55.05m
- -$43.13m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 9.78 | 13 | 38.2 | 80.1 | 80.7 |
Operating Profit | -9.78 | -13 | -38.2 | -80.1 | -80.7 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -9.31 | -12.9 | -35.2 | 5.16 | -71.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | -9.31 | -12.9 | -35.2 | 5.16 | -71.1 |
Net Income Before Extraordinary Items | |||||
Net Income | -9.31 | -12.9 | -35.2 | 5.16 | -71.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -9.31 | -12.9 | -35.2 | 5.16 | -71.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.079 | -0.109 | -0.294 | 0.04 | -0.487 |
Dividends per Share |